Парфенов В.А. Причины, диагностика и лечение боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика, 2009, 1: 19-22. / Parfyonov V.A. Causes, diagnosis and treatment of chronic nonspecific low back pain. Nevrologia, Neyropsikhiatria i Psikhosomatika, 2009, 1: 19-22.
Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М.: ГЭОТАР-Медиа, 2013. 368 с. / Podchufarova E.V., Yakhno N.N. Back pain. M.: GEOTAR Media, 2013. 368 p.
Мan Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J., 2006, 15(Suppl. 2): S.169-S.191.
Вахнина Н.В. Хроническая пояснично-крестцовая боль: диагностика и лечение. Неврология, нейропсихиатрия, психосоматика, 2010, 3: 30-34. / Vakhnina N.V. Chronic umbosacral pain: diagnosis and treatment. Nevrologia, Neyropsikhiatria i Psikhosomatika, 2010, 3: 30-34.
Подчуфарова Е.В., Яхно Н.Н. Боли в спине и конечностях. Болезни нервной системы под ред. Яхно Н.Н., Штульмана Д.Р. М.: Медицина, 2005. Т.2: 306-331. / Podchufarova E.V., Yakhno N.N. Pain in the back and limbs. Nervous system diseases ed. by Yakhno N.N., Shtulman D.R. М.: Meditsina, 2005. V. 2: 306-331.
European guidelines for the management of chronic nonspecific low back pain. Eur Spine J., 2006, 15(Suppl. 2): S192-S300.
Ferrell B, Argoff C.E., Epplin J et al. Pharmacological management of persistent pain in older persons. American geriatrics society panel on the pharmacological management of persistent pain in older persons. J Am Geriatr Soc, 2009, 57(8): 1331-46.
Strand Y, Hochberg MC. The risk of cardiovascular thrombotic events with selective cyclooxygenase- 2 inhibitors. Arthritis Care Res, 2002, 47: 349-255.
FitzGerald GA, Partono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J. Med., 2001, 345: 433-442.
Simon LS, Smolen JS, Abramson SB et al. Controversies in COX-2 selective inhibition. J. Rheumatology, 2002, 29: 1501-1510.
Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J., 2004 May, 18(7): 790-804.
Clark DW, Layton D, Shakir SA. Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology. Drug Saf., 2004, 27(7): 427-56.
Pareek A, Chandurkar N. Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double- blind study in patients with knee osteoarthritis. Curr Med Res Opin, 2013 Jul, 29(7): 849-59.
Schattenkirchner M, Milachowski KA. A doubleblind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheumatol, 2003 May, 22(2): 127-35.
Srijana Bhattarai, Himal Paudel Chhetri, Kadir Alam, Pabin Thapa A study on factors affecting low back pain and safety and efficacy of NSAIDs in acute low back pain in a Tertiary Care Hospital of Western Nepal. J Clin Diagn Res, 2013 Dec, 7(12): 2752-2758.
Лукина Е.В., Колоколов О.В., Колоколова А.М. Болевой синдром: возможности использования миорелаксантов. РМЖ, 2013, 16: 852-856. / Lukina E.V., Kolokolov O.V., Kolokolova A.M. Pain syndrome: prospects for the use of muscle relaxants. RMZ, 2013, 16: 852-856.
Coward DM. Tizanidine: neuropharmacology and mechanism of action. Neurology, 1994, 44(Suppl 9): 6-10.
Парфенов В.А., Батышева Т.Т. Боли в спине: болезненный мышечный спазм и его лечение миорелаксантами. Лечащий врач, 2003, 4: 34-37. / Parfenov V.A., Batysheva T.T. Back pain: painful muscle spasm and treatment with muscle relaxants. Lechaschiy Vrach, 2003, 4: 34-37.
Dulin J, Kovács L, Ramm S, Horvath F, Ebeling L, Kohnen R. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride Results of a prospective randomized double-blind placebocontrolled trial. Pharmacopsychiatry, 1998, 31(4): 137-42.
Шостак Н.А., Правдюк Н.Г., Егорова В.А. Боль в спине у пожилых – подходы к диагностике и лечению. Клиницист, 2011, 3: 72-77. / Shostak N.A., Pravdyuk N.G., Egorova V.A. Back pain in the elderly: approaches to diagnosis and treatment. Klinitsist, 2011, 3: 72- 77.
Sveinsdottir V, Eriksen HR, Reme SE. Assessing the role of cognitive behavioral therapy in the management of chronic nonspecific back pain. J Pain Res, 2012, 5: 371-380.
Мелкумова К.А. Когнитивно-поведенческая психотерапия при лечении хронической боли. Неврология, нейропсихиатрия, психосоматика, 2010, 1: 9-13. / Melkumova K.A. Cognitive-behavioral therapy in the treatment of chronic pain. Nevrologia, Neyropsikhiatria i Psikhosomatika, 2010, 1: 9-13.
Staal JB, Hlobil H, Twisk JW et al. Graded activity for low back pain in occupational health care: a randomized, controlled trial. Ann Intern Med, 2004, 140(2): 77-84.
Robert J, Gatchel, Kathryn H, Rollings. Evidence informed management of chronic low back pain with cognitive behavioral therapy. Spine J., 2008, 8: 40-44.